Test bank for Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition

,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
zr zr zr zr zr zr zr zr zr zr zr




Table of contents:zr zr



I. Principles Of Laboratory Medicine
zr zr zr zr



Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
zr zr zr zr zr zr zr zr



Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
zr zr zr zr zr zr zr zr zr zr zr



Chapter 3. Clinical Evaluation of Methods
zr zr zr zr zr



Chapter 4. Evidence-Based Laboratory Medicine
zr zr zr zr



Chapter 5. Establishment and Use of Reference Values
zr zr zr zr zr zr zr



Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
zr zr zr zr zr zr zr zr



Chapter 7. Quality Management
zr zr zr



II. Analytical Techniques And Instrumentation
zr zr zr zr



Chapter 8. Principles of Basic Techniques and Laboratory Safety
zr zr zr zr zr zr zr zr



Chapter 9. Optical Techniques
zr zr zr



Chapter 10. Electrochemistry and Chemical Sensors
zr zr zr zr zr



Chapter 11. Electrophoresis
zr zr



Chapter 12. Chromatography
zr zr



Chapter 13. Mass Spectrometry
zr zr zr



Chapter 14. Enzyme and Rate Analyses
zr zr zr zr zr



Chapter 15. Immunochemical Techniques
zr zr zr



Chapter 16 Automation zr zr



Chapter 17. Point-of-Care Instrumentation
zr zr zr



III. Analytes
z r



Chapter 18. Amino Acids, Peptides, and Proteins
zr zr zr zr zr zr



Chapter 19. Serum Enzymes
zr zr zr



Chapter 20. Tumor Markers and Cancer Genes
zr zr zr zr zr zr



Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
zr zr zr zr zr zr zr zr zr zr zr



Chapter 22. Carbohydrates
zr zr



Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
zr zr zr zr zr zr zr zr zr



Chapter 24. Electrolytes and Blood Gases
zr zr zr zr zr



Chapter 25. Hormones zr zr



Chapter 26. Catecholamines and Serotonin
zr z r zr zr



Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
zr z r zr zr zr zr



Chapter 28. Hemoglobin, Iron, and Bilirubin
zr zr zr zr zr



Chapter 29. Porphyrins and Porphyrias
zr zr zr zr



Chapter 30. Therapeutic Drugs and Their Management
zr zr zr zr zr zr



Chapter 31. Clinical Toxicology
zr zr zr



Chapter 32. Toxic Metals
zr z r zr



IV. Pathophysiology
z r



Chapter 33. Diabetes zr zr

,Chapter 34. Cardiovascular Disease
zr z r zr



Chapter 35. Kidney Disease
zr zr zr



Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
zr z r zr zr zr zr zr zr zr zr



Chapter 37. Liver Disease
zr z r zr



Chapter 38. Gastrointestinal and Pancreatic Diseases
zr z r zr zr zr



Chapter 39. Disorders of Bone and Mineral Metabolism
zr z r zr zr zr zr zr



Chapter 40. Disorders of the Pituitary Gland
zr z r zr zr zr zr



Chapter 41. Disorders of the Adrenal Cortex
zr z r zr zr zr zr



Chapter 42. Thyroid Disorders
zr z r zr



Chapter 43. Reproduction-Related Disorders
zr z r zr



Chapter 44. Pregnancy and Prenatal Testing
zr z r zr zr zr



Chapter 45. Newborn Screening and Inborn Errors of Metabolism
zr z r zr zr zr zr zr zr



Chapter 46. Pharmacogenetics
zr zr



V. Molecular Diagnostics
z r zr



Chapter 47. Principles of Molecular Biology
zr zr zr zr zr



Chapter 48. Nucleic Acid Techniques and Applications
zr zr zr zr zr zr



Chapter 49. Genomes and Nucleic Acid Alterations
zr zr zr zr zr zr

, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine TestBan
zr zr zr zr zr zr zr zr zr


k

MULTIPLE CHOICE zr




1. An individual working in a clinical chemistry laboratory is married to a sales representative
zr zr zr zr zr zr zr zr zr zr zr zr zr zr


who works for a company that sells chemistry laboratory supplies. When the laboratory man
zr zr zr zr zr zr zr zr zr zr zr zr zr


ager requests a list of needed supplies, cost of supplies, and vendors, this individual only reco
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


mmends the spouse’s company as the vendor. This is considered to be a(n):
zr zr zr zr zr zr zr zr zr zr zr zr


a. accounting issue. zr


b. possible conflict of interest. zr zr zr


c. maintenance of confidentiality issue. zr zr zr


d. problem with resource allocation. zr zr zr




ANS: B zr


Concern has been raised over the interrelationships between practitioners in the medical field a
zr zr zr zr zr zr zr zr zr zr zr zr zr


nd commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
zr zr zr zr zr zr zr zr zr zr zr


Similarly, relationships have been scrutinized between clinical laboratorians and manufacture
zr zr zr zr zr zr zr zr zr


rs and providers of diagnostic equipment and supplies. These concerns led the National Instit
zr zr zr zr zr zr zr zr zr zr zr zr zr


utes of Health (NIH) in 1995 to require official institutional review of financial disclosure by r
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


esearchers and management of situations in which disclosure indicates potential conflicts of in
zr zr zr zr zr zr zr zr zr zr zr zr


terest.

DIF: 1 REF: z r Page 4-5 zr OBJ: 6 | 7 zr zr zr




2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


the pain following her recent surgery. A friend of the patient claims that the same painkiller
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


―worked wonders‖ to reduce her pain after the same surgery. The physician states that the
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


difference in the effect of the drug might be caused by zr zr zr zr zr zr zr zr zr zr


, which is studied in pharmacoge zr zr zr zr zr


netics.
a. epidemiology
b. an inherited disease zr zr


c. a conflict of interest
zr zr zr


d. a genetic variation in drug-metabolizing enzymes
zr zr zr zr zr




ANS: D zr


Pharmacogenetics is the study of the genetic variation of drug metabolism between individ zr zr zr zr zr zr zr zr zr zr zr zr


uals.

DIF: 1 REF: zrzr Page 3 zr OBJ: 1 zr




3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


name of a close friend printed on the bar-
zr zr zr zr zr zr zr zr


coded label. The genetic test that is ordered on the friend’s sample would provide diagnosti
zr zr zr zr zr zr zr zr zr zr zr zr zr zr


c information about a disorder that has a poor prognosis, and the test is usually performed
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


by John. He asks a fellow employee to analyze the sample for him and not divulge the resu
zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr zr


lts. This ethical issue concerns:
zr zr zr zr


a. confidentiality of patient genetic and medical information. zr zr zr zr zr zr


b. a conflict of interest.
zr zr zr


c. resource allocation. zr


d. diagnostic accuracy. zr